Skip to main content
icon for Cyclosporiasis cases in U.S. by July 31?

Cyclosporiasis cases in U.S. by July 31?

icon for Cyclosporiasis cases in U.S. by July 31?

Cyclosporiasis cases in U.S. by July 31?

$50,926 Wol.

Jul 31, 2026
Polymarket

$50,926 Wol.

Polymarket

5000+

$10,227 Wol.

Yes

7500+

$199 Wol.

No

10000+

$17,235 Wol.

No

1800+

$3,663 Wol.

Yes

2000+

$5,096 Wol.

Yes

2500+

$7,808 Wol.

Yes

3000+

$6,697 Wol.

Yes

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.A major 2026 cyclosporiasis outbreak has driven elevated U.S. case counts through the typical May–July seasonal peak, with CDC confirming domestically acquired infections across multiple states linked primarily to contaminated fresh produce such as lettuce. As of late July, Michigan alone reported over 10,000 cases, while a single multistate cluster tied to Taco Bell locations exceeded 1,644 illnesses; Washington and other states added dozens more. These totals far surpass historical baselines of 200–1,000 annual illnesses from roughly a dozen outbreaks. Official CDC surveillance data through July 31 will incorporate delayed laboratory reports and interviews, with final national figures subject to revision. Traders monitoring resolution should watch for any CDC updates on total confirmed cases meeting the market’s geographic and temporal criteria.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Wolumen
$50,926
Data zakończenia
Jul 31, 2026
Rynek otwarty
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

Wynik zaproponowany: Yes

Brak sporu

Ostateczny wynik: Yes

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.A major 2026 cyclosporiasis outbreak has driven elevated U.S. case counts through the typical May–July seasonal peak, with CDC confirming domestically acquired infections across multiple states linked primarily to contaminated fresh produce such as lettuce. As of late July, Michigan alone reported over 10,000 cases, while a single multistate cluster tied to Taco Bell locations exceeded 1,644 illnesses; Washington and other states added dozens more. These totals far surpass historical baselines of 200–1,000 annual illnesses from roughly a dozen outbreaks. Official CDC surveillance data through July 31 will incorporate delayed laboratory reports and interviews, with final national figures subject to revision. Traders monitoring resolution should watch for any CDC updates on total confirmed cases meeting the market’s geographic and temporal criteria.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Wolumen
$50,926
Data zakończenia
Jul 31, 2026
Rynek otwarty
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

Wynik zaproponowany: Yes

Brak sporu

Ostateczny wynik: Yes

Uważaj na linki zewnętrzne.

Często zadawane pytania

"Cyclosporiasis cases in U.S. by July 31?" to rynek prognoz na Polymarket z 7 możliwymi wynikami, gdzie traderzy kupują i sprzedają udziały na podstawie tego, co ich zdaniem się wydarzy. Obecny wiodący wynik to "5000+" z 100%, za nim "1800+" z 100%. Ceny odzwierciedlają zbiorowe prawdopodobieństwa w czasie rzeczywistym. Na przykład udział wyceniony na 100¢ implikuje, że rynek zbiorowo przypisuje 100% szansy na ten wynik. Te kursy zmieniają się ciągle, gdy traderzy reagują na nowe informacje. Udziały w poprawnym wyniku można wymienić na $1 za sztukę po rozstrzygnięciu rynku.

Na dzień dzisiejszy "Cyclosporiasis cases in U.S. by July 31?" wygenerował $50.9K łącznego wolumenu od uruchomienia rynku Jul 14, 2026. Ten poziom aktywności handlowej odzwierciedla silne zaangażowanie społeczności Polymarket i pomaga zapewnić, że bieżące kursy są informowane przez głęboką pulę uczestników rynku. Możesz śledzić ruchy cen na żywo i handlować na dowolny wynik bezpośrednio na tej stronie.

Aby handlować na "Cyclosporiasis cases in U.S. by July 31?", przeglądaj 7 dostępnych wyników na tej stronie. Każdy wynik wyświetla bieżącą cenę reprezentującą implikowane prawdopodobieństwo rynku. Aby zająć pozycję, wybierz wynik, który uważasz za najbardziej prawdopodobny, wybierz "Tak", aby handlować na jego korzyść, lub "Nie", aby handlować przeciw niemu, wpisz kwotę i kliknij "Handluj". Jeśli wybrany wynik okaże się poprawny, Twoje udziały "Tak" wypłacą $1 za sztukę. Jeśli jest niepoprawny, wypłacą $0. Możesz też sprzedać swoje udziały w dowolnym momencie przed rozstrzygnięciem.

Obecnym faworytem dla "Cyclosporiasis cases in U.S. by July 31?" jest "5000+" z 100%, co oznacza, że rynek przypisuje 100% szansy na ten wynik. Następny najbliższy wynik to "1800+" z 100%. Te kursy aktualizują się w czasie rzeczywistym, gdy traderzy kupują i sprzedają udziały, odzwierciedlając najnowszy zbiorowy pogląd na to, co jest najbardziej prawdopodobne. Sprawdzaj regularnie lub dodaj tę stronę do zakładek, aby śledzić zmiany kursów.

Zasady rozstrzygania "Cyclosporiasis cases in U.S. by July 31?" określają dokładnie, co musi się wydarzyć, aby każdy wynik został ogłoszony zwycięzcą — w tym oficjalne źródła danych używane do ustalenia wyniku. Możesz przejrzeć pełne kryteria rozstrzygania w sekcji "Zasady" na tej stronie nad komentarzami. Zalecamy dokładne zapoznanie się z zasadami przed handlem, ponieważ określają one precyzyjne warunki, przypadki graniczne i źródła regulujące rozstrzyganie tego rynku.